NCT00499343 - G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Lymphoma

Interventions

DRUG

Etoposide

150 mg/m\^2 given intravenously over 2 hours every 12 hours x 6 doses.

DRUG

G-CSF

Starting dose on day +6 at 6 mcg/kg injection every 12 hours until completion of apheresis.

DRUG

GM-CSF

250 mcg/m\^2 injection given every evening till the completion of apheresis.

DRUG

Isophosphamide

10 g/m\^2 given intravenously continuous infusion over 72 hours.

DRUG

Rituximab

Days +1 (375 mg/m\^2) and +8 (1000 mg/m\^2) given intravenously.

PROCEDURE

Apheresis

Peripheral blood stem cell collection.

Trial Locations (1)

U.T.M.D. Anderson Cancer Center, Houston